1. Ahi, Ehsan Pashay, Lecaudey, Laurène A, Ziegelbecker, Angelika, Goessler, Walter, Sefc, Kristina M. 2020. Expression levels of the tetratricopeptide repeat protein gene ttc39b covary with carotenoid-based skin colour in cichlid fish. In Biology letters, 16, 20200629. doi:10.1098/rsbl.2020.0629. https://pubmed.ncbi.nlm.nih.gov/33236977/
2. Wang, Tao-Tao, Yang, Cheng-Yong, Peng, Li, Xu, Tao, Chen, Yun-Zhi. 2023. QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 123, 155192. doi:10.1016/j.phymed.2023.155192. https://pubmed.ncbi.nlm.nih.gov/37951148/
3. Teslovich, Tanya M, Musunuru, Kiran, Smith, Albert V, Boehnke, Michael, Kathiresan, Sekar. . Biological, clinical and population relevance of 95 loci for blood lipids. In Nature, 466, 707-13. doi:10.1038/nature09270. https://pubmed.ncbi.nlm.nih.gov/20686565/
4. Hsieh, Joanne, Molusky, Matthew M, McCabe, Kristin M, DaSilva-Jardine, Paul, Tall, Alan R. 2021. TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. In Journal of hepatology, 76, 383-393. doi:10.1016/j.jhep.2021.09.021. https://pubmed.ncbi.nlm.nih.gov/34600974/
5. Hsieh, Joanne, Koseki, Masahiro, Molusky, Matthew M, Rader, Daniel J, Tall, Alan R. 2016. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis. In Nature, 535, 303-7. doi:10.1038/nature18628. https://pubmed.ncbi.nlm.nih.gov/27383786/